Theriva Biologics, Inc.
Q1 2026 13F Holders
Symbol
TOVX
CUSIP
87164U508
Type
Equity
Class
COM NEW
Num filings
22
Total reported value, excl. options
$385 k
Compare 2026 Q1 to
2026 Q2
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type